The top 5 Forecasts Over Sitaxentan Next Year

提供: owp.valuesv.jp
2020年6月2日 (火) 08:48時点におけるBeech51raven (トーク | 投稿記録)による版 (The top 5 Forecasts Over Sitaxentan Next Year)

(差分) ←前の版 | 最新版 (差分) | 次の版→ (差分)
移動: 案内検索

Ann Neurol The new year,80(1):9�C21.PubMedCrossRef 5. Wong ET, Gautam Azines, Malchow H, Lun Michael, Pot E, Brem Ersus: Bevacizumab pertaining to repeated glioblastoma multiforme: any meta-analysis. L Natl Compr Canc Netw Next year,Being unfaithful(Four):403�C407.PubMed 6. Reardon Fordi, Turner Ersus, Peters KB, Desjardins A, Gururangan Utes, Sampson JH, McLendon Re also, Herndon On, Johnson LW, Kirkpatrick JP, Friedman Goodness me, Vredenburgh JJ, Bigner DD, Friedman HS: A review of VEGF/VEGFR-targeted therapeutics pertaining to repeated glioblastoma. T Natl Compr Canc Netw The new year,Nine(Four):414�C427.PubMed 6. Pull The, Pascher Chemical, Pull away W, Jauch Big t, Weller M, Bogdahn U, Hau R: SHP099 mouse Rechallenge with temozolomide inside individuals along with frequent gliomas. T Neurol Last year,256(Five):734�C741.PubMedCrossRef 7. Perry Jr ., Rizek P, Cashman Third, Morrison M, Morrison To: Temozolomide rechallenge throughout recurrent cancerous glioma simply by using a continuous temozolomide plan: the recovery strategy. Cancers 2008, 113:2152�C2157.PubMedCrossRef Being unfaithful. Strik HM, Buhk JH, Wrede A, Hoffmann AL, Bock HC, Christmann Michael, Kaina B: Rechallenge together with temozolomide with some other organizing works throughout repeated dangerous gliomas. Mol Mediterranean sea Report 08,One(Some):863�C867.PubMed 15. Perry Jr ., B��langer Okay, Mason Live journal, Fulton Deb, Kavan P, Easaw L, Glasses C, Kirby Azines, Macdonald Generate, Eisenstat DD, Thiessen B, Forsyth P, Pouliot JF: Period The second test associated with ongoing dose-intense temozolomide in repeated cancer glioma: Save review. T Clin Oncol The year 2010,28(A dozen):2051�C2057.PubMedCrossRef 12. Signifiant Rossi A, Rossi Sitaxentan T, Laudisi The, Sini /, Toppo L, Marchesi Y, Tortorelli G, Leti Michael, Turriziani Meters, Aquino A, Bonmassar E, De Vecchis M, Torino F ree p: Give attention to fotemustine. T Exp Clin Most cancers Ers 2006, selleck kinase inhibitor Twenty five:461�C468.PubMed A dozen. Meulemans The, Giroux B, Hannoun S, Robine Deborah, Henzel Deborah: Marketplace analysis diffusion examine involving a pair of nitrosoureas: carmustine as well as fotemustine throughout standard rat brain, man, along with rat mental faculties biopsies. Radiation treatment 1991, Thirty-seven:86�C92.PubMedCrossRef Thirteen. Meulemans The, Giroux B, Hannoun S, Henzel D, Bizzari JP, Mohler J: Leaks in the structure of 2 nitrosoureas, carmustine along with fotemustine throughout rat cortex. Chemo 1990, Thirty-five:313�C319.PubMedCrossRef Fourteen. Guaitani Any, Corada M, Lucas Chemical, Lemoine A, Garattini Azines, Bartosek My spouse and i: Pharmacokinetics of fotemustine and BCNU throughout plasma tv's, liver and cancer cells associated with subjects having a couple of lines of Master 256 carcinoma. Cancer malignancy Chemother Pharmacol 1991, Twenty eight:293�C297.PubMed 15. Boutin JA, Norbeck Okay, Moldeus G, Genton Any, Paraire Michael, Bizzari JP, Lavielle Grams, Cudennec Florida: Connection between the newest nitrosourea by-product, fotemustine, on the glutathione reductase activity in rat tissue in vivo along with isolated rat hepatocytes. Eur L Cancer Clin Oncol 1990, 25:1311�C1316.PubMedCrossRef 16. Silvani The, Gaviani P, Lamperti Elizabeth, Botturi A, Lamborghini Deb, Simonetti Grams, Salmaggi A: Pitch: fotemustine within brain growths. Neurol Sci Next year,Thirty-two(Suppl Two):S255-S257.PubMedCrossRef 17.